Biosensors Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035)
Dublin, Sept. 14, 2026 (GLOBE NEWSWIRE) -- "Biosensors Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035)" has been added to ResearchAndMarkets.com's offering.
Biosensors Market to Reach USD 15.79 Billion by 2035 as Demand for Rapid Diagnostics and Wearable Devices Accelerates
The global biosensors market was valued at USD 8.49 billion in 2025 and is projected to reach USD 15.79 billion by 2035, expanding at a compound annual growth rate (CAGR) of 6.40% from 2026 to 2035. Market growth is being supported by the rising burden of chronic diseases, increasing demand for rapid diagnostics, continued innovation in wearable biosensors, and broader adoption of point-of-care testing.
Integration with digital health platforms, remote patient monitoring systems, and connected medical devices is strengthening the role of biosensor technology in modern healthcare. Applications are also expanding beyond clinical diagnostics into environmental monitoring, food and beverage testing, research laboratories, security, and biodefence.
Latest Biosensors Market Developments
April 2026: Novel Biosensor Advances Single-Cell Brain Research
Researchers introduced a biosensor capable of mapping zinc signaling at single-cell resolution in the brain. The development broadens the potential use of neurobiosensors in neuroscience, precision diagnostics, and research into neurological disease pathways. Growing investment in cellular-level analysis and precision medicine is expected to create further opportunities for advanced biosensing platforms.
March 2026: Graphene Enhances Biomolecular Detection
Research published in March 2026 demonstrated that graphene could improve biosensor sensitivity by as much as 600%, supporting more accurate biomolecular detection. This advancement reinforces the commercial potential of graphene-based biosensors in precision healthcare, early disease detection, and next-generation diagnostic systems.
Industry collaboration is also supporting graphene biosensor development. In November 2025, Melexis and Graphenea partnered to advance miniaturized graphene-based biosensors with enhanced detection capabilities. Such initiatives are expected to improve device performance, accelerate commercialization, and encourage the adoption of advanced materials across the biosensors industry.
Biosensors Market Highlights
Key Biosensors Market Growth Drivers and Trends
The increasing prevalence of diabetes, cardiovascular disorders, infectious diseases, and other chronic conditions is generating sustained demand for continuous monitoring and early diagnostic solutions. Wearable biosensors are gaining momentum as healthcare providers and patients seek real-time health data, improved disease management, and more personalized treatment pathways.
Point-of-care testing is anticipated to remain a major end-user segment, supported by decentralized healthcare delivery, faster clinical decision-making, and growing demand for accessible diagnostic services. The segment accounted for approximately 56% of market demand during the historical period and is expected to benefit from continued adoption across hospitals, clinics, pharmacies, and home healthcare environments.
Technological progress in electrochemical, optical, piezoelectric, thermal, and nanomechanical platforms is improving biosensor sensitivity, accuracy, connectivity, and miniaturization. Electrochemical biosensors have maintained a particularly strong position, accounting for around 69% of historical market share due to their extensive use in glucose monitoring and other clinical diagnostic applications.
Biosensors Market Segmentation
By product, the market includes wearable and non-wearable biosensors. Wearable categories cover wristwear, eyewear, footwear, neckwear, bodywear, and other connected formats. Technology segments include electrochemical, amperometric, potentiometric, conductometric, optical, surface plasmon resonance, colorimetric, fluorescence, piezoelectric, acoustic, microcantilever, thermal, and nanomechanical biosensors.
Key components include bioreceptor molecules, biological elements, and transducers. Major applications encompass point-of-care diagnostics, glucose monitoring, cardiac marker testing, infectious disease detection, coagulation monitoring, pregnancy testing, blood gas and electrolyte analysis, cancer marker detection, urinalysis, cholesterol testing, home diagnostics, environmental monitoring, food and beverage testing, research, and biodefence.
Principal end users include point-of-care testing providers, home healthcare diagnostic users, food industry participants, research laboratories, and security and biodefence organizations. The regional market covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
North America Leads Regional Market Growth
North America is expected to lead the global biosensors market with a share of nearly 35%. Regional growth is supported by advanced healthcare infrastructure, established reimbursement systems, substantial investment in digital health, and high adoption of wearable medical technologies. Increasing use of biosensors for diabetes management, chronic disease monitoring, and point-of-care diagnostics is reinforcing the region's market position.
Europe and Asia Pacific also present significant growth opportunities. Expanding healthcare access, rising diagnostic demand, technology investment, and increasing awareness of preventive care are expected to support biosensor adoption across these regions during the forecast period.
Leading Companies in the Biosensors Market
AgaMatrix Holdings LLC develops connected blood glucose meters and digital diabetes management technologies, with an emphasis on accuracy and patient-centered care. Abbott Laboratories Inc. maintains a strong market position through its FreeStyle Libre continuous glucose monitoring systems and broader portfolio of diagnostic and medical technologies.
Biosensors International Group, Ltd. focuses on medical devices, cardiovascular technologies, and diagnostic solutions, while Medtronic plc offers continuous glucose monitoring systems, implantable devices, digital health integration, and advanced analytics for chronic disease management.
Other prominent biosensors market participants include Bio-Rad Laboratories Inc., Pinnacle Technologies Inc., Ercon, Inc., DuPont Biosensor Materials, Koninklijke Philips N.V., QTL Biodetection LLC, Molecular Devices Corporation, Nova Biomedical, Molex LLC, Zimmer & Peacock AS, and Siemens Healthineers.
Competitive strategies across the market include patent development, research funding, technology partnerships, product innovation, mergers, acquisitions, and commercialization agreements. As demand for rapid, connected, and high-sensitivity diagnostic systems rises, companies are expected to increase investment in wearable platforms, advanced materials, and precision healthcare applications.
Key Topics Covered:
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biosensors Market Overview
3.1 Global Biosensors Market Historical Value (2019-2025)
3.2 Global Biosensors Market Forecast Value (2026-2035)
4 Global Biosensors Market Landscape
4.1 Global Biosensors Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Biosensors Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Biosensors Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Biosensors Market Segmentation
6.1 Global Biosensors Market by Product
6.1.1 Market Overview
6.1.2 Wearable
6.1.2.1 Wristwear
6.1.2.2 Eyewear
6.1.2.3 Footwear
6.1.2.4 Neckwear
6.1.2.5 Bodywear
6.1.2.6 Others
6.1.3 Non-Wearable
6.2 Global Biosensors Market by Technology
6.2.1 Market Overview
6.2.2 Electrochemical
6.2.2.1 Amperometric Sensor
6.2.2.2 Potentiometric Sensor
6.2.2.3 Conductometric Sensor
6.2.3 Optical
6.2.3.1 SPR
6.2.3.2 Colorimetric Biosensors
6.2.3.3 Fluorescence Biosensors
6.2.4 Piezoelectric
6.2.4.1 Acoustic Biosensors
6.2.4.2 Microcantilever Biosensors
6.2.5 Thermal Biosensor
6.2.6 Nanomechanical
6.3 Global Biosensors Market by Component
6.3.1 Market Overview
6.3.2 Bioreceptor Molecule
6.3.3 Biological Element
6.3.4 Transducer
6.4 Global Biosensors Market by Application
6.4.1 Market Overview
6.4.2 POC
6.4.2.1 Glucose Monitoring
6.4.2.2 Cardiac Marker
6.4.2.3 Infectious Disease Detection
6.4.2.4 Coagulation Monitoring
6.4.2.5 Pregnancy Testing
6.4.2.6 Blood Gas and Electrolyte Detection
6.4.2.7 Detection of Tumor or Cancer Marker
6.4.2.8 Urinalysis Testing
6.4.2.9 Cholesterol Testing
6.4.3 Home Diagnostic
6.4.3.1 Glucose Monitoring
6.4.3.2 Pregnancy Testing
6.4.3.3 Cholesterol Testing
6.4.4 Research Labs
6.4.5 Environmental Monitoring
6.4.6 Food and Beverages
6.4.7 Biodefence
6.5 Global Biosensors Market by End User
6.5.1 Market Overview
6.5.2 Home Healthcare Diagnostics
6.5.3 POC Testing
6.5.4 Food Industry
6.5.5 Research Laboratories
6.5.6 Security and Biodefence
6.6 Global Biosensors Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Bladder Cancer Treatment Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Bladder Cancer Treatment Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Bladder Cancer Treatment Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Bladder Cancer Treatment Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Bladder Cancer Treatment Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 AgaMatrix Holdings LLC
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Abbott Laboratories Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Biosensors International Group, Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Medtronic Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Bio-Rad Laboratories Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Pinnacle Technologies Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Ercon, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Dupont Biosensors Materials
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Koninklijke Philips N.V.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Qtl Biodetection Llc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Molecular Devices Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Nova Biomedical
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Molex Llc
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Zimmer & Peacock As
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Siemens Healthcare
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Biosensors Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
Companies Featured
For more information about this report visit https://www.researchandmarkets.com/r/g57h2n
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.